TrialThe international journal of neuropsychopharmacology2021

Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder: A Phase 2b, Randomized, Placebo-Controlled, Adaptive Dose-Finding Study.

Adam Savitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.